| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/26/2009 | US20090081733 Methods for producing and using polymyxins |
| 03/26/2009 | US20090081732 Antibodies to human il-1beta |
| 03/26/2009 | US20090081731 Method of producing catalytically active BACE2 enzymes |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081728 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences |
| 03/26/2009 | US20090081727 CD33-Like Protein |
| 03/26/2009 | US20090081726 Recombinant Microorganism |
| 03/26/2009 | US20090081725 Compositions of pamps and Listeria monocytogenes and methods of use |
| 03/26/2009 | US20090081724 identifying a subject predisposed to a disorder associated with ion channel dysfunction; epilepsy; isolated nucleic acid molecule encoding a mutant or variant ion channel subunit |
| 03/26/2009 | US20090081718 Protein cleavage method and thereof |
| 03/26/2009 | US20090081715 Engineered Light-Emitting Reporter Genes |
| 03/26/2009 | US20090081705 Novel peptides and compositions which modulate apoptosis |
| 03/26/2009 | US20090081692 Ceramide Kinase Loop |
| 03/26/2009 | US20090081673 Platensimycin biosynthetic gene cluster of streptomyces platensis |
| 03/26/2009 | US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081642 Novel apoptosis gene EI24, compositions, and methods of use |
| 03/26/2009 | US20090081331 Phytase |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081242 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 03/26/2009 | US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein |
| 03/26/2009 | US20090081240 Human Anti-Kir Antibodies |
| 03/26/2009 | US20090081238 Anti-notch1 NRR antibodies and methods using same |
| 03/26/2009 | US20090081230 Human cytomegalovirus neutralising antibodies and use thereof |
| 03/26/2009 | US20090081227 Promotong differentiation of neural stem cells to nerve cells for use in treating injury to central nerve system caused by brain infarction, hemorrhage and/or spinal cord injury |
| 03/26/2009 | US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF |
| 03/26/2009 | US20090081218 Fusion proteins |
| 03/26/2009 | US20090081207 High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| 03/26/2009 | US20090081204 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/26/2009 | US20090081188 Complex of factorix and polyoxyethylene glycol; stimulant blood coagulation; blood disorders |
| 03/26/2009 | US20090081144 Cosmetic compositions |
| 03/26/2009 | US20090081126 Novel fully human anti-VAP-1 monoclonal antibodies |
| 03/26/2009 | US20090078384 Esterases from rumen |
| 03/26/2009 | CA2706889A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 03/25/2009 | EP2039763A1 Production of peroxidase from plant cell and callus cultures |
| 03/25/2009 | EP2039704A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 03/25/2009 | EP2039251A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 03/25/2009 | EP2038423A2 A method of producing biologically active polypeptide having insulinotropic activity |
| 03/25/2009 | EP2037892A2 Modified factor viii and factor ix genes and vectors for gene therapy |
| 03/25/2009 | EP1920239A4 Detection and measurement of blood-feeding activity |
| 03/25/2009 | EP1882744A4 Method for producing an interleukin-2 preparation and the thus obtainable preparation |
| 03/25/2009 | EP1833979A4 Nucleic acid molecules for optimized cab-2 expression and their use |
| 03/25/2009 | EP1299421B1 Antibodies to human mcp-1 |
| 03/25/2009 | EP1287035B1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 03/25/2009 | EP1238282B1 Methods of diagnosis and treatment by binding p75/airm1 |
| 03/25/2009 | CN101395282A Promoter engineering and genetic control |
| 03/25/2009 | CN101395162A Hapten compound and antibody |
| 03/25/2009 | CN101392283A Enzymatic hydrolysis method for extracting high F value oligopeptide mixture from rana chensinensis egg oil |
| 03/25/2009 | CN101391095A Production technique of bone peptide calcium |
| 03/25/2009 | CN101390881A Preparation of wood louse powder extract and uses thereof |
| 03/25/2009 | CN100471957C Adenovirus vectors for immunotherapy |
| 03/24/2009 | US7507872 Transgenic toll-like receptor 9 (TLR9) mice |
| 03/24/2009 | US7507807 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 03/24/2009 | US7507804 Peptides and nucleic acid sequences related to the Epstein Barr Virus |
| 03/24/2009 | US7507795 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 03/24/2009 | US7507793 Mammalian sweet taste receptors t1r3 |
| 03/24/2009 | US7507792 MDA-7 proteins and methods of use thereof |
| 03/24/2009 | US7507706 Administering a polypeptide to reduce airway hyper responsiveness or reduce the increase of mucus-containing cells in the airway epithelium; IL-13 binding chains of the interleukin-13 receptor |
| 03/24/2009 | US7507574 Recombinant Saccharomyces cerevisiae expressing chimeric glucose transporters |
| 03/24/2009 | US7507573 Genetically engineered methylotrophic yeast for use as bioreactor in production of glycoproteins with mammalian-like glycosylation |
| 03/24/2009 | US7507570 Recombinant chondroitinase ABC I and uses thereof |
| 03/24/2009 | US7507559 reacting acyclic carboxy amines with 5,10-methylene tetrahydrofolic acid in the presence of formaldehyde and a protein derived from a microorganism, to form oxy carboxy amines and its optically-active isomers |
| 03/24/2009 | US7507557 Nucleotide sequences coding proline utilization protein (PUT2) for use as tool in prevention and treatment of insulin metabolic disorders |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507529 genetic amplification of a target nucleic acid in biological samples containing primate T-lymphotropic viruses (PTLVs), include human and simian T-lymphotropic viruses (HTLV and STLV), and detecting the strain of PTLV contained in the sample by determining nucleotide fragments that have been amplified |
| 03/24/2009 | US7507417 Glycoproteins; antigens |
| 03/24/2009 | US7507412 for drug screening; kits for collagen and/or platelet-collagen interaction; for treatment of thrombotic and cardiovascular events and disorders |
| 03/24/2009 | US7507411 Attenuated influenza NS1 variants |
| 03/24/2009 | US7507410 Monoclonal antibody DS6, tumor-associated antigen CA6, and methods of use thereof |
| 03/24/2009 | US7507408 Anti hepatitis C virus antibody and uses thereof |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | CA2223911C The preparation of active peptides |
| 03/24/2009 | CA2017186C Bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 03/19/2009 | WO2009036385A2 Expression of nucleic acid sequences for production of biofuels and other products in algae and cyanobacteria |
| 03/19/2009 | WO2009036067A2 Molecule production by photosynthetic organisms |
| 03/19/2009 | WO2009035412A1 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 03/19/2009 | WO2009033259A1 An anti-cancer cytotoxic monoclonal antibody |
| 03/19/2009 | WO2009017679A3 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders |
| 03/19/2009 | WO2009009103A3 CRYSTALS AND STRUCTURE OF HUMAN IgG Fc VARIANT |
| 03/19/2009 | WO2009006548A3 Treatment for anxiety |
| 03/19/2009 | WO2008156551A3 Tat signal peptides for producing proteins in prokaryotes |
| 03/19/2009 | WO2008122550A3 Pulverizer and corresponding method for preparing a biological sample for processing |
| 03/19/2009 | WO2005076785A3 Method and compositions for detecting botulinum neurotoxin |
| 03/19/2009 | WO2005062977A3 Prostate cancer specific internalizing human antibodies |
| 03/19/2009 | US20090076143 Compositions and methods for treating inflammation and inflammation-related disorders by plectranthus amboinicus extracts |
| 03/19/2009 | US20090075927 Sweet taste receptors |
| 03/19/2009 | US20090075925 Methods and Compositions Related to APOBEC-1 Expression |
| 03/19/2009 | US20090075900 Therapeutic agent for motor neuron disease |
| 03/19/2009 | US20090075889 Iren protein, its preparation and use |
| 03/19/2009 | US20090075880 Albumin Fusion Proteins |
| 03/19/2009 | US20090075871 Modified Thioredoxin |
| 03/19/2009 | US20090075839 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigents and uses thereof |
| 03/19/2009 | US20090075388 Stable isotope-labeled aliphatic amino acids, method for incorporating the same in target protein and method for nmr-structural analysis of proteins |
| 03/19/2009 | US20090075341 Il-21 antagonists |
| 03/19/2009 | US20090075340 Kir-Binding Agents and Methods of Use Thereof |
| 03/19/2009 | US20090075339 Autophilic antibodies |
| 03/19/2009 | US20090075338 Dimeric fusion proteins and materials and methods for producing them |